Development and external validation of a prognostic nomogram for metastatic uveal melanoma

Approximately 50% of patients with uveal melanoma (UM) will develop metastatic disease, usually involving the liver. The outcome of metastatic UM (mUM) is generally poor and no standard therapy has been established. Additionally, clinicians lack a validated prognostic tool to evaluate these patients...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2015-03, Vol.10 (3), p.e0120181-e0120181
Hauptverfasser:	Valpione, Sara, Moser, Justin C, Parrozzani, Raffaele, Bazzi, Marco, Mansfield, Aaron S, Mocellin, Simone, Pigozzo, Jacopo, Midena, Edoardo, Markovic, Svetomir N, Aliberti, Camillo, Campana, Luca G, Chiarion-Sileni, Vanna
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Analysis Cancer metastasis Cancer therapies Chemotherapy Clinical decision making Clinical trials Decision making Development and progression Female Gastroenterology Gene expression Humans Immunotherapy Kinases Liver Liver diseases Male Medical diagnosis Medical prognosis Medical research Melanoma Melanoma - pathology Metastases Metastasis Middle Aged Neoplasm Metastasis Nomograms Oncology Patients Phosphatase Prognosis Skin cancer Survival Survival Analysis Tomography Uveal Neoplasms - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!